KYVERNA THERAPEUTICS INC (KYTX:NASDAQ)
$8.95 -0.63 (-6.5762%)
Analysed KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) News Sources
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
09-04-2026
yahoo.com
The Oncology Institute Names Minh Merchant Chief Legal Officer
06-04-2026
yahoo.com
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
26-03-2026
yahoo.com
Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026
05-03-2026
yahoo.com
Kyverna Therapeutics to Participate in Upcoming March Investor Conferences
03-03-2026
yahoo.com
Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors
24-02-2026
yahoo.com
Wall Street Thinks These 4 Biotech Stocks Will Double–At Least–This Year
16-02-2026
247wallst.com
Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology Officer
03-02-2026
yahoo.com
Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference
12-01-2026
yahoo.com
Kyverna Therapeutics to Present at the J.P. Morgan 2026 Healthcare Conference
05-01-2026
yahoo.com
What is the current price of KYVERNA THERAPEUTICS INC (KYTX:NASDAQ)?
The current price of KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) is $8.95.
KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) since the previous trading day is $-0.63.
KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) since the previous trading day is -6.5762%.
What is the most recent average sentiment score for KYVERNA THERAPEUTICS INC (KYTX:NASDAQ)?
The most recent average sentiment score for KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for KYVERNA THERAPEUTICS INC (KYTX:NASDAQ)?
The most recent sentiment for KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) is .
SEC-8K** Filing Available For KYVERNA THERAPEUTICS INC (KYTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.